3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
146
Head and Neck Neoplasms
80
Squamous Cell Carcinoma of Head and Neck
69
Rectal Neoplasms
46
Colonic Neoplasms
42
Carcinoma, Non-Small-Cell Lung
39
Neoplasm Metastasis
35
Neoplasms
25
Carcinoma, Squamous Cell
20
Pancreatic Neoplasms
17
Lung Neoplasms
16
Esophageal Neoplasms
15
Stomach Neoplasms
12
Recurrence
11
Laryngeal Neoplasms
11
Mouth Neoplasms
10
Oropharyngeal Neoplasms
8
Esophageal Squamous Cell Carcinoma
8
Breast Neoplasms
8
Adenocarcinoma Of Esophagus
8
Tongue Neoplasms
7
Uterine Cervical Neoplasms
6
Nasopharyngeal Carcinoma
6
Laryngeal Diseases
6
Hypopharyngeal Neoplasms
6
Colorectal Cancer Metastatic
6
Carcinoma
6
Adenocarcinoma of Lung
6
Salivary Gland Neoplasms
5
Cholangiocarcinoma
4
Interventions
Chemoradiotherapy
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Resectable Esophageal Cancer
×
Cetuximab
×
Clear all
NCT00827671
2018-03-09
TRACC
UMC Utrecht
Phase 2
Terminated
12 enrolled